lobbying_activities: 1695487
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1695487 | 593c20f9-1e4c-411a-8fe2-5d6f71b14087 | Q2 | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 35968 | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015 | second_quarter | LAW | Issues relating to a controlled substance nuclear medicine drug. | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Energy, Dept of,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),Office of Science & Technology Policy (OSTP),SENATE | 90000 | 0 | 0 | 2015-07-15T09:29:24.027000-04:00 |